BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 23680151)

  • 21. The WD40 domain of FBXW7 is a poly(ADP-ribose)-binding domain that mediates the early DNA damage response.
    Zhang Q; Mady ASA; Ma Y; Ryan C; Lawrence TS; Nikolovska-Coleska Z; Sun Y; Morgan MA
    Nucleic Acids Res; 2019 May; 47(8):4039-4053. PubMed ID: 30722038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation.
    Minten EV; Kapoor-Vazirani P; Li C; Zhang H; Balakrishnan K; Yu DS
    Cell Rep; 2021 Mar; 34(13):108921. PubMed ID: 33789098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.
    Nakamura K; Saredi G; Becker JR; Foster BM; Nguyen NV; Beyer TE; Cesa LC; Faull PA; Lukauskas S; Frimurer T; Chapman JR; Bartke T; Groth A
    Nat Cell Biol; 2019 Mar; 21(3):311-318. PubMed ID: 30804502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
    Zhang L; Li DQ
    Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thermodynamic study of the BRCT domain of BARD1 and its interaction with the -pSER-X-X-Phe- motif-containing BRIP1 peptide.
    Thanassoulas A; Nomikos M; Theodoridou M; Yannoukakos D; Mastellos D; Nounesis G
    Biochim Biophys Acta; 2010 Sep; 1804(9):1908-16. PubMed ID: 20451671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CTCF participates in DNA damage response via poly(ADP-ribosyl)ation.
    Han D; Chen Q; Shi J; Zhang F; Yu X
    Sci Rep; 2017 Mar; 7():43530. PubMed ID: 28262757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRCA1-mediated ubiquitylation.
    Boulton SJ
    Cell Cycle; 2006 Jul; 5(14):1481-6. PubMed ID: 16861894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in Expression of Key DNA Damage Repair Genes after Epigenetic-Induced BRCAness Dictate Synthetic Lethality with PARP1 Inhibition.
    Wiegmans AP; Yap PY; Ward A; Lim YC; Khanna KK
    Mol Cancer Ther; 2015 Oct; 14(10):2321-31. PubMed ID: 26294743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex.
    Kim HS; Li H; Cevher M; Parmelee A; Fonseca D; Kleiman FE; Lee SB
    Cancer Res; 2006 May; 66(9):4561-5. PubMed ID: 16651405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair.
    Morris JR; Solomon E
    Hum Mol Genet; 2004 Apr; 13(8):807-17. PubMed ID: 14976165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mRNA Processing Factor CstF-50 and Ubiquitin Escort Factor p97 Are BRCA1/BARD1 Cofactors Involved in Chromatin Remodeling during the DNA Damage Response.
    Fonseca D; Baquero J; Murphy MR; Aruggoda G; Varriano S; Sapienza C; Mashadova O; Rahman S; Kleiman FE
    Mol Cell Biol; 2018 Feb; 38(4):. PubMed ID: 29180510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes.
    Stewart MD; Zelin E; Dhall A; Walsh T; Upadhyay E; Corn JE; Chatterjee C; King MC; Klevit RE
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):1316-1321. PubMed ID: 29367421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Luring BRCA1 to the scene of the crime.
    Baer R
    Cancer Cell; 2013 May; 23(5):565-7. PubMed ID: 23680142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(ADP-ribosyl)ation is recognized by ECT2 during mitosis.
    Li M; Bian C; Yu X
    Cell Cycle; 2014; 13(18):2944-51. PubMed ID: 25486481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.
    Dizin E; Irminger-Finger I
    Int J Biochem Cell Biol; 2010 May; 42(5):693-700. PubMed ID: 20060929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of BARD1 targeting and dynamics at the centrosome: the role of CRM1, BRCA1 and the Q564H mutation.
    Brodie KM; Mok MTS; Henderson BR
    Cell Signal; 2012 Feb; 24(2):451-459. PubMed ID: 21982881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Analysis of BRCA1 in Human Breast Cancer Cells Under Oxidative Stress.
    Gilmore BL; Liang Y; Winton CE; Patel K; Karageorge V; Varano AC; Dearnaley W; Sheng Z; Kelly DF
    Sci Rep; 2017 Mar; 7():43435. PubMed ID: 28262780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential modulation of BRCA1 and BARD1 nuclear localisation and foci assembly by DNA damage.
    Brodie KM; Henderson BR
    Cell Signal; 2010 Feb; 22(2):291-302. PubMed ID: 19796682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional Analysis of BARD1 Missense Variants in Homology-Directed Repair of DNA Double Strand Breaks.
    Lee C; Banerjee T; Gillespie J; Ceravolo A; Parvinsmith MR; Starita LM; Fields S; Toland AE; Parvin JD
    Hum Mutat; 2015 Dec; 36(12):1205-14. PubMed ID: 26350354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimodal approach to explore the pathogenicity of BARD1, ARG 658 CYS, and ILE 738 VAL mutants.
    Choudhary RK; Vikrant ; Siddiqui QM; Thapa PS; Raikundalia S; Gadewal N; Kumar NS; Hosur MV; Varma AK
    J Biomol Struct Dyn; 2016 Jul; 34(7):1533-44. PubMed ID: 26307947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.